177 related articles for article (PubMed ID: 22819973)
1. Effects of peripheral κ opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats.
Auh QS; Ro JY
Neurosci Lett; 2012 Aug; 524(2):111-5. PubMed ID: 22819973
[TBL] [Abstract][Full Text] [Related]
2. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia.
Lawson KP; Nag S; Thompson AD; Mokha SS
Pain; 2010 Dec; 151(3):806-815. PubMed ID: 20926192
[TBL] [Abstract][Full Text] [Related]
3. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
4. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
[TBL] [Abstract][Full Text] [Related]
5. Nonopioid actions of U50,488 enantiomers contribute to their peripheral cutaneous antinociceptive effects.
Joshi SK; Gebhart GF
J Pharmacol Exp Ther; 2003 Jun; 305(3):919-24. PubMed ID: 12626643
[TBL] [Abstract][Full Text] [Related]
6. A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain.
Edwards KA; Havelin JJ; Mcintosh MI; Ciccone HA; Pangilinan K; Imbert I; Largent-Milnes TM; King T; Vanderah TW; Streicher JM
J Pain; 2018 Jun; 19(6):612-625. PubMed ID: 29371114
[TBL] [Abstract][Full Text] [Related]
7. The effect of intrathecal mu, delta, kappa, and alpha-2 agonists on thermal hyperalgesia induced by mild burn on hind paw in rats.
Kim HJ; Seol TK; Lee HJ; Yaksh TL; Jun JH
J Anesth; 2011 Dec; 25(6):884-91. PubMed ID: 21983967
[TBL] [Abstract][Full Text] [Related]
8. Activation of κ Opioid Receptors in Cutaneous Nerve Endings by Conorphin-1, a Novel Subtype-Selective Conopeptide, Does Not Mediate Peripheral Analgesia.
Deuis JR; Whately E; Brust A; Inserra MC; Asvadi NH; Lewis RJ; Alewood PF; Cabot PJ; Vetter I
ACS Chem Neurosci; 2015 Oct; 6(10):1751-8. PubMed ID: 26225903
[TBL] [Abstract][Full Text] [Related]
9. Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia.
Auh QS; Chun YH; Melemedjian OK; Zhang Y; Ro JY
Brain Res Bull; 2016 Jul; 125():211-7. PubMed ID: 27450703
[TBL] [Abstract][Full Text] [Related]
10. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway.
Cunha TM; Souza GR; Domingues AC; Carreira EU; Lotufo CM; Funez MI; Verri WA; Cunha FQ; Ferreira SH
Mol Pain; 2012 Feb; 8():10. PubMed ID: 22316281
[TBL] [Abstract][Full Text] [Related]
12. Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats.
Zhou X; Wang D; Zhang Y; Zhang J; Xiang D; Wang H
BMC Endocr Disord; 2015 Feb; 15():7. PubMed ID: 25887435
[TBL] [Abstract][Full Text] [Related]
13. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
[TBL] [Abstract][Full Text] [Related]
14. No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Britch SC; Craft RM
Behav Pharmacol; 2021 Dec; 32(8):630-639. PubMed ID: 34561365
[TBL] [Abstract][Full Text] [Related]
15. A single, extinction-based treatment with a kappa opioid receptor agonist elicits a long-term reduction in cocaine relapse.
Heinsbroek JA; Furbish AB; Peters J
Neuropsychopharmacology; 2018 Jun; 43(7):1492-1497. PubMed ID: 29472645
[TBL] [Abstract][Full Text] [Related]
16. Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects.
Su X; Joshi SK; Kardos S; Gebhart GF
J Neurophysiol; 2002 Mar; 87(3):1271-9. PubMed ID: 11877501
[TBL] [Abstract][Full Text] [Related]
17. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
Yu XC; Li HY; Wang HX; Wong TM
J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the antinociceptive effect of oxycodone in male and female rats.
Holtman JR; Wala EP
Pharmacol Biochem Behav; 2006 Jan; 83(1):100-8. PubMed ID: 16434089
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
Stein C; Millan MJ; Yassouridis A; Herz A
Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
[TBL] [Abstract][Full Text] [Related]
20. Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction.
Peart JN; Gross ER; Gross GJ
J Cardiovasc Pharmacol; 2004 Mar; 43(3):410-5. PubMed ID: 15076225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
